Analyst Raises Price Target on Silver Co. With Acquisition Offer
Source: Joe Reagor 08/21/2025
MAG Silver Corp. (MAG:TSX; MAG:NYSE American) just released its Q2 2025 financial results, slightly exceeding expectations. Find out why one firm is raising its price target on the stock.
MAG Silver Corp. (MAG:TSX; MAG:NYSE American) just released its Q2 2025 financial results and they slightly exceeded Roth Capital Partners’ expectations, the firm said an updated research note.
Roth raised its price target on the stock from US$22 to US$23 to align with the current value of the Pan-American Silver Corp. (PAAS-NC) offer, while maintaining its Neutral rating.
MAG’s earnings per share of US$0.32 surpassed Roth’s forecast of US$0.27, primarily due to lower effective tax rates at both the joint venture and corporate levels, wrote Roth Managing Director and Senior Research Analyst Joe Reagor.
“We also note that capital spending at the Juanicipio JV (joint venture) was lower than anticipated but is expected to increase in the second half of 2025,” Reagor wrote.
Raising Price Target to US$23
Although the results exceeded the firm’s projections, they did not directly influence its valuation of MAG. The valuation continued to be based on the mark-to-market offer from PAAS. Therefore, Roth increased its price target from US$22 to US$23, while keeping its Neutral rating unchanged.
The price target for MAG is determined by the current prorated value of PAAS’s offer, Reagor noted. With PAAS’s share price at US$31.64, we estimate a prorated value of US$22.65 per MAG share. We round this up to set our price target at US$23.
Factors that could cause MAG’s share price to diverge from our target include, but are not limited to, dilutive transactions, variations in asset performance or metal prices, cost overruns, operational or technical challenges, and other unforeseen events, Reagor said.
Sign up for our FREE newsletter at: www.streetwisereports.com/get-news
Important Disclosures:
- MAG Silver Corp. is a billboard sponsor of Streetwise Reports and pays SWR a monthly sponsorship fee between US$4,000 and US$5,000.
- Steve Sobek wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an employee.
- This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.
For additional disclosures, please click here.
Disclosures for Roth Capital Partners, MAG Silver Corp., August 12, 2025:
ROTH makes a market in shares of MAG Silver Corp. and as such, buys and sells from customers on a principal basis.
ROTH Capital Partners, LLC and its affiliates expects to receive or intends to seek compensation for investment banking or other business relationships with the covered companies mentioned in this report in the next three months. The material, information and facts discussed in this report other than the information regarding ROTH Capital Partners, LLC and its affiliates, are from sources believed to be reliable, but are in no way guaranteed to be complete or accurate. This report should not be used as a complete analysis of the company, industry or security discussed in the report. Additional information is available upon request. This is not, however, an offer or solicitation of the securities discussed. Any opinions or estimates in this report are subject to change without notice. An investment in the stock may involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Additionally, an investment in the stock may involve a high degree of risk and may not be suitable for all investors. No part of this report may be reproduced in any form without the express written permission of ROTH. Copyright 2025. Member: FINRA/SIPC.
( Companies Mentioned: MAG:TSX; MAG:NYSE American, )
Source: https://www.streetwisereports.com/article/2025/08/21/analyst-raises-price-target-on-silver-co-with-acquisition-offer.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
